See bandrami's comment https://news.ycombinator.com/item?id=11999413 https://news.ycombinator.com/item?id=11999413 as well as this: > The biotech company Amg

See bandrami's comment https://news.ycombinator.com/item?id=11999413 https://news.ycombinator.com/item?id=11999413 as well as this: > The biotech company Amgen Inc. and prominent biochemist Bruce Alberts have created a new online journal that aims to lift the curtain on often hidden results in biomedicine: failed efforts to confirm other groups’ published papers. Amgen is seeding the publication with reports on its own futile attempts to replicate three studies in diabetes and neurodegenerative disease and hopes other companies will follow suit. > The contradictory results—along with successful confirmations—will be published by F1000Research, an open-access, online-only publisher. Its new “Preclinical Reproducibility and Robustness channel,” launched today, will allow both companies and academic scientists to share their replications so that others will be less likely to waste time following up on flawed findings, says Sasha Kamb, senior vice president for research at Amgen in Thousand Oaks, California. http://www.sciencemag.org/news/2016/02/if-you-fail-reproduce-another-scientist-s-results-journal-wants-know http://www.sciencemag.org/news/2016/02/if-you-fail-reproduce...